Cargando…
Claudin-5: gatekeeper of neurological function
Tight junction proteins of the blood–brain barrier are vital for maintaining integrity of endothelial cells lining brain blood vessels. The presence of these protein complexes in the space between endothelial cells creates a dynamic, highly regulated and restrictive microenvironment that is vital fo...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350359/ https://www.ncbi.nlm.nih.gov/pubmed/30691500 http://dx.doi.org/10.1186/s12987-019-0123-z |
_version_ | 1783390438298746880 |
---|---|
author | Greene, Chris Hanley, Nicole Campbell, Matthew |
author_facet | Greene, Chris Hanley, Nicole Campbell, Matthew |
author_sort | Greene, Chris |
collection | PubMed |
description | Tight junction proteins of the blood–brain barrier are vital for maintaining integrity of endothelial cells lining brain blood vessels. The presence of these protein complexes in the space between endothelial cells creates a dynamic, highly regulated and restrictive microenvironment that is vital for neural homeostasis. By limiting paracellular diffusion of material between blood and brain, tight junction proteins provide a protective barrier preventing the passage of unwanted and potentially damaging material. Simultaneously, this protective barrier hinders the therapeutic effectiveness of central nervous system acting drugs with over 95% of small molecule therapeutics unable to bypass the blood–brain barrier. At the blood–brain barrier, claudin-5 is the most enriched tight junction protein and its dysfunction has been implicated in neurodegenerative disorders such as Alzheimer’s disease, neuroinflammatory disorders such as multiple sclerosis as well as psychiatric disorders including depression and schizophrenia. By regulating levels of claudin-5, it is possible to abrogate disease symptoms in many of these disorders. This review will give an overview of the blood–brain barrier and the role of tight junction complexes in maintaining blood–brain barrier integrity before focusing on the role of claudin-5 and its regulation in homeostatic and pathological conditions. We will also summarise therapeutic strategies to restore integrity of cerebral vessels by targeting tight junction protein complexes. |
format | Online Article Text |
id | pubmed-6350359 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63503592019-02-04 Claudin-5: gatekeeper of neurological function Greene, Chris Hanley, Nicole Campbell, Matthew Fluids Barriers CNS Review Tight junction proteins of the blood–brain barrier are vital for maintaining integrity of endothelial cells lining brain blood vessels. The presence of these protein complexes in the space between endothelial cells creates a dynamic, highly regulated and restrictive microenvironment that is vital for neural homeostasis. By limiting paracellular diffusion of material between blood and brain, tight junction proteins provide a protective barrier preventing the passage of unwanted and potentially damaging material. Simultaneously, this protective barrier hinders the therapeutic effectiveness of central nervous system acting drugs with over 95% of small molecule therapeutics unable to bypass the blood–brain barrier. At the blood–brain barrier, claudin-5 is the most enriched tight junction protein and its dysfunction has been implicated in neurodegenerative disorders such as Alzheimer’s disease, neuroinflammatory disorders such as multiple sclerosis as well as psychiatric disorders including depression and schizophrenia. By regulating levels of claudin-5, it is possible to abrogate disease symptoms in many of these disorders. This review will give an overview of the blood–brain barrier and the role of tight junction complexes in maintaining blood–brain barrier integrity before focusing on the role of claudin-5 and its regulation in homeostatic and pathological conditions. We will also summarise therapeutic strategies to restore integrity of cerebral vessels by targeting tight junction protein complexes. BioMed Central 2019-01-29 /pmc/articles/PMC6350359/ /pubmed/30691500 http://dx.doi.org/10.1186/s12987-019-0123-z Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Greene, Chris Hanley, Nicole Campbell, Matthew Claudin-5: gatekeeper of neurological function |
title | Claudin-5: gatekeeper of neurological function |
title_full | Claudin-5: gatekeeper of neurological function |
title_fullStr | Claudin-5: gatekeeper of neurological function |
title_full_unstemmed | Claudin-5: gatekeeper of neurological function |
title_short | Claudin-5: gatekeeper of neurological function |
title_sort | claudin-5: gatekeeper of neurological function |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350359/ https://www.ncbi.nlm.nih.gov/pubmed/30691500 http://dx.doi.org/10.1186/s12987-019-0123-z |
work_keys_str_mv | AT greenechris claudin5gatekeeperofneurologicalfunction AT hanleynicole claudin5gatekeeperofneurologicalfunction AT campbellmatthew claudin5gatekeeperofneurologicalfunction |